Press Releases

01.05.2021

Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Healthcare Conference

01.04.2021

US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency

12.29.2020

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

12.28.2020

LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA

12.28.2020

Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women's Health

12.23.2020

Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

12.22.2020

Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts

12.21.2020

Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine

12.21.2020

Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine

12.14.2020

Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2

12.12.2020

U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older

12.11.2020

Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19